

Fundamental dimension Equity attribute | BUSELeader $30.33▼-0.13% Cap $2.50BP/E 10.9x QuantScore63/100 | BANFPeer $111.21▼-1.02% Cap $3.74BP/E 14.6x QuantScore49/100 | BFCPeer $147.34▲+1.36% Cap $1.63BP/E 18.4x QuantScore48/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
94/100 |
76/100 |
52/100 |
Valuation Multiples, PEG & DCF upside | 97/100 | 55/100 | 77/100 |
Health Piotroski, Altman Z, leverage & liquidity | 49/100 | 50/100 | 37/100 |
Growth Revenue / earnings growth & margins | 67/100 | 34/100 | 53/100 |
Sentiment Analyst ratings, targets & revisions | 9/100 | 32/100 | 22/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 10.9x | 14.6x | 18.4x |
Forward P/E (next FY) | 11.9x | 14.4x | 15.0x |
EV / EBITDA (TTM) | 12.6x | -1.4x | 13.2x |
Price / Sales | 2.7x | 4.4x | 5.1x |
Price / Free Cash Flow | 12.1x | 20.6x | 38.4x |
PEG ratio | 0.08 | 2.08 | 1.45 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 5 / 9 | 7 / 9 |
Altman Z-Score | 0.24 (Distress) | 0.78 (Distress) | -0.54 (Distress) |
Total debt / equity | 0.19 | 0.00 | 0.10 |
Quick ratio | 3.8x | 373.1x | 0.2x |
Interest coverage | 0.5x | 1.1x | 1.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +57.6% | -9.3% | +7.7% |
Net income growth YoY | +19.0% | +11.2% | +9.0% |
Gross margin (TTM) | 66.1% | 84.2% | 75.1% |
Operating margin (FY) | 17.9% | 36.8% | 36.7% |
FCF margin (FY) | 16.6% | 28.7% | 21.2% |
5. Trailing price performancePrice change over period |
1M return | +0.8% | +3.6% | -3.1% |
3M return | +1.6% | -4.6% | -2.3% |
6M return | +15.9% | -2.0% | +2.2% |
Year to date | +27.5% | +4.9% | +20.9% |
1Y return | +30.7% | -1.4% | +12.6% |
3Y return | +64.7% | +37.0% | +92.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $50.44 +66.3% upside | $46.46 -58.2% premium | $214.65 +45.7% upside |
Wall Street consensus target | $31.50 +3.9% · range $28.00–$35.00 | $125.00 +12.4% · range $125.00–$125.00 | $161.00 +9.3% · range $161.00–$161.00 |
Consensus stance | 27% Buy73% Hold0% Sell | 0% Buy67% Hold33% Sell | 33% Buy67% Hold0% Sell |